<DOC>
	<DOCNO>NCT00372008</DOCNO>
	<brief_summary>Testosterone replacement treatment effective way treat hypogonadism men . Acrux proprietry testosterone replacement product - Testosterone-MD Lotion , study evaluate efficacy safety product .</brief_summary>
	<brief_title>Pharmacokinetics Testosterone Lotion Treatment Hypogonadal Males</brief_title>
	<detailed_description />
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Hypogonadal males 1870 year old qualify general medical health Disqualifying concurrent condition allergy/sensitivity testosterone replacement therapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>